Updated on 22 October 2013
With a shared goal of improving knowledge on maternal, infant and child nutrition and development, the board assists local doctors and nurses across Asia to keep up with the latest scientific discoveries in the area of child development.
What are the current ongoing clinical studies in Asia?
Ms Le Quesne: Globally, Fonterra spends $50 million annually on scientific research, an investment that includes ongoing research into nutrition, maternal and infant health, and child development.
Our research programme has specifically focused on the needs of Asian populations to guide the development of high quality products and to support the health and wellness needs of families in the region.
Fonterra has had a strong focus on maternal and paediatric health, and it was this focus that drove the development of our Anmum brand.
Dietary folic acid is well known for its pivotal role in preventing the birth defect of spina bifida. At the time when little was known about folate status in Asian women Anmum began a research programme to quantify the problem of folate inadequacy in Asia. The results revealed that four-out-of-five women were at risk of folate inadequacy.